InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,947.27
(
-0.25%
)
Post# of 252969
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: oc631 post# 156462

Tuesday, 02/05/2013 11:12:13 AM

Tuesday, February 05, 2013 11:12:13 AM

Post# of 252969
You are thinking of patients while GILD is thinking of making max profit.
I'm not even sure the 7% difference doesn't show stst-sig non inferiority to SOC and while I agree that the right way would be to separate GT2 and 3 and find a better combo for GT3, I think that in light of SOC, no options, no resistance, the FDA will approve.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up